Yixin Lin
About Yixin Lin
Yixin Lin is a Senior Manager at Bristol Myers Squibb, specializing in scientific content and market capabilities for immunology and fibrosis. Lin has extensive experience in the pharmaceutical industry, having worked in various roles and completed numerous rotations and internships.
Company
Yixin Lin currently works at Bristol Myers Squibb as the Senior Manager for World Wide Scientific Content & US Market Capabilities, specializing in Immunology and Fibrosis. This role is based in Princeton, New Jersey, United States. Lin started this position in January 2021, where he contributes to the development of scientific content, enhancing the company's market capabilities in the immunology and fibrosis sectors.
Title
Yixin Lin holds the title of Senior Manager, WW Scientific Content & US Market Capabilities, Immunology/Fibrosis. In this role, he oversees the generation and dissemination of key scientific content related to immunology and fibrosis, working with both internal and external stakeholders to deepen Bristol Myers Squibb's market impact and scientific authority in these areas.
Education and Expertise
Yixin Lin studied at Rutgers, The State University of New Jersey-New Brunswick, where he achieved a Doctor of Pharmacy (Pharm.D.) degree from 2011 to 2017. His education provided a foundation in pharmacy, pharmacology, and toxicology, which was further enriched by research engagements through the Pharm.D. Honors Research Program at Rutgers University.
Background
Yixin Lin has a diverse background in the pharmaceutical industry. Before becoming a Senior Manager, he has served in various roles, including Manager of WW Scientific Content & US Market Capabilities at Bristol Myers Squibb in 2020, and as a Medical Information Associate at APCER Life Sciences from 2017 to 2020. Lin's experience also includes several APPE rotations and internships at organizations like the FDA, Novartis, and AstraZeneca.
Achievements
Lin's most notable achievements include contributing to the enhancement of scientific content for immunology and fibrosis at Bristol Myers Squibb. This work has fortified the company's market capabilities and scientific reputation. Moreover, his three-year tenure at APCER Life Sciences equipped him with substantial experience in medical information management. His advanced practice rotations in specialties like clinical psychiatry and internal medicine further underscore his comprehensive expertise in the pharmaceutical field.